{"product_id":"understanding-how-blood-flow-forces-affect-heart-artery-plaque-a-patients-guide-to-new-research","title":"Understanding How Blood Flow Forces Affect Heart Artery Plaque: A Patient's Guide to New Research","description":"\u003cp\u003eNew research reveals that two mechanical forces acting on coronary arteries—wall shear stress (the friction from blood flow) and mechanical wall stress (the stretching from blood pressure)—both play significant roles in the development and progression of atherosclerosis. Following 34 patients over 12 months, researchers found that higher mechanical wall stress was linked to new plaque formation in previously clear artery segments, while specific combinations of these forces influenced both plaque growth and regression. These findings could help doctors better predict which areas of the coronary arteries are most vulnerable to plaque build-up, potentially guiding more personalized monitoring and treatment strategies.\u003c\/p\u003e\n\n\u003ch1\u003eUnderstanding How Blood Flow Forces Affect Heart Artery Plaque: A Patient's Guide to New Research\u003c\/h1\u003e\n\n\u003ch2\u003eTable of Contents\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003e\u003ca href=\"#ddn-key-points\"\u003eKey Points\u003c\/a\u003e\u003c\/li\u003e\n\n  \u003cli\u003e\u003ca href=\"#background\"\u003eWhy This Research Matters: The Basics of Heart Artery Plaque\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#methods\"\u003eHow the Study Was Conducted: Patients, Imaging, and Computer Models\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#findings-thickness\"\u003eKey Findings: Changes in Artery Wall Thickness\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#findings-composition\"\u003eKey Findings: Changes in Plaque Composition\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#clinical\"\u003eWhat This Means for Patients: Clinical Implications\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#limitations\"\u003eStudy Limitations: What This Research Could Not Prove\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#recommendations\"\u003eRecommendations for Patients: What You Can Do\u003c\/a\u003e\u003c\/li\u003e\n  \u003cli\u003e\u003ca href=\"#ddn-faq\"\u003eFrequently Asked Questions\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca href=\"#source\"\u003eSource Information\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003c!-- ddn:keypoints:start --\u003e\n\u003ch2 id=\"ddn-key-points\"\u003eKey Points\u003c\/h2\u003e\n\u003cul\u003e\n\u003cli\u003eIn a 12-month study of 34 patients, higher mechanical wall stress from blood pressure was linked to new plaque growth in previously clear coronary artery segments.\u003c\/li\u003e\n\u003cli\u003eHigher wall shear stress and mechanical wall stress were each associated with greater plaque shrinkage, likely due to statin therapy, in a study of 34 patients.\u003c\/li\u003e\n\u003cli\u003eAcross all patients, lipid-rich necrotic core inside plaques shrank by 54% on average, and 85% of plaque areas improved while taking statins.\u003c\/li\u003e\n\u003cli\u003eThe combination of low mechanical wall stress and high wall shear stress was linked to increasing lipid core, a potentially dangerous plaque change.\u003c\/li\u003e\n\u003cli\u003ePatients are advised to take blood pressure medications and statins, control other risk factors, and talk with their cardiologist about plaque and treatment goals.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c!-- ddn:keypoints:end --\u003e\n\n\n\u003ch2 id=\"background\"\u003eWhy This Research Matters: The Basics of Heart Artery Plaque\u003c\/h2\u003e\n\n\u003cp\u003eAtherosclerosis—the buildup of plaque inside the coronary arteries that supply blood to the heart—is the leading cause of heart attacks worldwide. But plaque doesn't form uniformly throughout the arteries. Some spots develop dangerous blockages while neighboring areas remain clear. This patchy distribution has puzzled researchers for decades.\u003c\/p\u003e\n\n\u003cp\u003eThe answer may lie in local biomechanical forces—the physical stresses that blood flow and blood pressure exert on the artery walls. Two forces in particular have captured researchers' attention, and a new study from Erasmus Medical Center in the Netherlands investigated how these forces work together to influence plaque behavior.\u003c\/p\u003e\n\n\u003cp\u003eThe first force is \u003cstrong\u003ewall shear stress (WSS)\u003c\/strong\u003e, which is the frictional force created by blood flowing over the endothelial cells—the delicate inner lining of the artery. Think of it like the drag you feel when holding your hand out of a moving car window. The second force is \u003cstrong\u003emechanical wall stress (MWS)\u003c\/strong\u003e, the structural stress inside the artery wall itself caused by blood pressure. This is like the tension you feel in a balloon's rubber as you inflate it—the pressure from inside stretches and strains the material.\u003c\/p\u003e\n\n\u003cp\u003eWhile wall shear stress has been extensively studied, mechanical wall stress has received surprisingly little attention in relation to plaque development. Most previous MWS research focused only on late-stage plaque rupture, which is what triggers heart attacks. This study, published in the journal \u003cem\u003eAtherosclerosis\u003c\/em\u003e, took a broader approach: it examined how both forces, individually and in combination, influence plaque initiation, growth, and regression over time.\u003c\/p\u003e\n\n\u003ch2 id=\"methods\"\u003eHow the Study Was Conducted: Patients, Imaging, and Computer Models\u003c\/h2\u003e\n\n\u003ch3\u003eStudy Design and Patient Population\u003c\/h3\u003e\n\n\u003cp\u003eThe study was embedded within a prospective, single-center observational cohort study at Erasmus University Medical Center in Rotterdam, the Netherlands. Initially, \u003cstrong\u003e53 patients\u003c\/strong\u003e were enrolled. All had experienced \u003cstrong\u003eacute coronary syndrome\u003c\/strong\u003e (a condition that includes heart attacks and unstable angina), were hemodynamically stable, and had at least one non-stented, non-culprit coronary artery suitable for invasive imaging and physiology measurements.\u003c\/p\u003e\n\n\u003cp\u003ePatients with certain conditions were excluded from the study. These included:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003ePrior coronary artery bypass graft (CABG) surgery\u003c\/li\u003e\n  \u003cli\u003eThree-vessel coronary disease\u003c\/li\u003e\n  \u003cli\u003eRenal insufficiency (kidney failure)\u003c\/li\u003e\n  \u003cli\u003eLeft ventricular ejection fraction below 30% (significantly reduced heart pumping function)\u003c\/li\u003e\n  \u003cli\u003eAtrial fibrillation (an irregular heart rhythm)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eOf the 53 patients initially included, \u003cstrong\u003e19 were excluded\u003c\/strong\u003e from the final analysis due to consent withdrawal or missing\/low-quality imaging or pressure data. The final analysis included \u003cstrong\u003e34 coronary arteries from 34 patients\u003c\/strong\u003e. The average age was \u003cstrong\u003e62 years (plus or minus 8.9 years)\u003c\/strong\u003e, and \u003cstrong\u003e91.2% were men\u003c\/strong\u003e. The average body mass index (BMI) was \u003cstrong\u003e27 (plus or minus 4.6)\u003c\/strong\u003e—technically in the overweight range.\u003c\/p\u003e\n\n\u003cp\u003eCardiovascular risk factors were common in this group:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eDiabetes mellitus: 17.6% (6 patients)\u003c\/li\u003e\n  \u003cli\u003eHypertension: 23.5% (8 patients)\u003c\/li\u003e\n  \u003cli\u003eHypercholesterolemia: 44.1% (15 patients)\u003c\/li\u003e\n  \u003cli\u003eCurrent smoking: 17.6% (6 patients)\u003c\/li\u003e\n  \u003cli\u003ePositive family history: 38.2% (13 patients)\u003c\/li\u003e\n  \u003cli\u003ePrevious heart attack (myocardial infarction): 21.6% (7 patients)\u003c\/li\u003e\n  \u003cli\u003ePrevious angioplasty (PCI): 24.3% (8 patients)\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eTheir average LDL cholesterol (the \"bad\" cholesterol) was \u003cstrong\u003e2.6 mmol\/L\u003c\/strong\u003e (ranging from 2.1 to 3.2 mmol\/L). Notably, \u003cstrong\u003e17 patients were already taking statins\u003c\/strong\u003e at the start of the study, another \u003cstrong\u003e15 started statin therapy within one month\u003c\/strong\u003e, and the remaining two began statin treatment at the sixth and eleventh months after their first coronary imaging. By the 12-month follow-up, all patients were on statin therapy.\u003c\/p\u003e\n\n\u003ch3\u003eImaging Procedures\u003c\/h3\u003e\n\n\u003cp\u003eThe researchers imaged one non-culprit artery per patient—meaning an artery that was not responsible for the original heart event. These included \u003cstrong\u003e13 left anterior descending arteries (LAD)\u003c\/strong\u003e, \u003cstrong\u003e11 right coronary arteries (RCA)\u003c\/strong\u003e, and \u003cstrong\u003e10 left circumflex arteries (LCX)\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eTwo sophisticated imaging techniques were used at both baseline and after 12 months:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eNear-infrared spectroscopy with intravascular ultrasound (NIRS-IVUS)\u003c\/strong\u003e: This combined technique uses sound waves to create detailed cross-sectional images of the artery wall and simultaneously uses light spectroscopy to detect the chemical signature of lipid-rich necrotic cores (LRNC)—the dangerous, cholesterol-filled core of atherosclerotic plaques.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eOptical coherence tomography (OCT)\u003c\/strong\u003e: A high-resolution imaging technique that uses light waves to produce extremely detailed images of the artery's inner structures, like an \"optical biopsy\" of the blood vessel.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eAdditionally, one month after the initial procedure, patients underwent a \u003cstrong\u003ecoronary computed tomography angiogram (CCTA)\u003c\/strong\u003e—a specialized CT scan of the heart arteries. All arterial segments studied were at least 30 mm long. Blood flow and pressure were measured within each segment using a special guidewire called a ComboWire.\u003c\/p\u003e\n\n\u003ch3\u003eComputational Modeling\u003c\/h3\u003e\n\n\u003cp\u003eThis study's technology-heavy approach involved creating \u003cstrong\u003epatient-specific computer models\u003c\/strong\u003e of each coronary artery. Researchers used the imaging data to build three-dimensional reconstructions of the artery geometry—including the inner lumen (the blood-carrying channel) and the vessel wall, which consists of the intima\/media layer and the adventitia (the outer supportive layer). A 0.15 mm uniform layer was added around the external elastic lamina to account for the mechanical contribution of the adventitia.\u003c\/p\u003e\n\n\u003cp\u003eFor \u003cstrong\u003ewall shear stress (WSS)\u003c\/strong\u003e, the team used \u003cstrong\u003ecomputational fluid dynamics (CFD)\u003c\/strong\u003e—computer simulations of blood flow. Blood was modeled as an incompressible, homogeneous Carreau fluid (a mathematical model that captures how blood thickens at low flow rates), and the artery walls were assumed to be rigid. Patient-specific flow measurements from the ComboWire were used to set the inlet and outlet conditions. Time-averaged wall shear stress values were calculated for the entire cardiac cycle.\u003c\/p\u003e\n\n\u003cp\u003eFor \u003cstrong\u003emechanical wall stress (MWS)\u003c\/strong\u003e, the researchers used \u003cstrong\u003efinite element (FE) modeling\u003c\/strong\u003e—a computer technique that breaks a complex structure into tiny elements to calculate stress and strain. Since the arteries were imaged while under blood pressure (not at zero pressure), a special \"backward incremental method\" was used to compute the initial stresses that existed at the time of imaging. Artery-specific blood pressure measurements were incorporated into the models. The tissues were modeled as isotropic, nonlinear, hyperelastic, and incompressible materials, using approximately 5,000 finite elements per cross-section. The researchers reported both the \u003cstrong\u003emaximum luminal MWS\u003c\/strong\u003e (stress at the inner surface of the artery) and the \u003cstrong\u003eaverage MWS within the vessel wall\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eSector Analysis and Statistics\u003c\/h3\u003e\n\n\u003cp\u003eTo study local effects, each coronary artery was divided into small sectors measuring \u003cstrong\u003e1.5 mm in length and 45 degrees in circumference\u003c\/strong\u003e. Cross-sections at side-branch locations were excluded because the artery circumference wasn't complete at those points. This yielded \u003cstrong\u003e6,527 individual sectors\u003c\/strong\u003e for analysis.\u003c\/p\u003e\n\n\u003cp\u003eSectors were categorized as either \u003cstrong\u003eplaque-free\u003c\/strong\u003e (mean wall thickness less than 0.5 mm) or \u003cstrong\u003eplaque sectors\u003c\/strong\u003e (mean wall thickness greater than 0.5 mm). Plaque sectors were further divided into those \u003cstrong\u003ewith LRNC\u003c\/strong\u003e (NIRS positive percentage greater than 50%) or \u003cstrong\u003ewithout LRNC\u003c\/strong\u003e (NIRS positive percentage less than 50%).\u003c\/p\u003e\n\n\u003cp\u003eThe researchers then calculated how much each sector's wall thickness changed over the year (ΔWT) and how the lipid-rich necrotic core percentage changed (ΔLRNC). For statistical analysis, baseline WSS and MWS values were divided into \u003cstrong\u003etertiles—low, mid, and high\u003c\/strong\u003e—with specific threshold values for each sector type. A statistical method called \u003cstrong\u003elinear mixed models\u003c\/strong\u003e was used to account for the fact that multiple sectors from the same artery are not fully independent of each other. All analyses corrected for baseline wall thickness, statin treatment, and cardiovascular risk factors including diabetes, hypertension, hypercholesterolemia, smoking, obesity, and family history. A p-value below 0.05 was considered statistically significant.\u003c\/p\u003e\n\n\u003ch2 id=\"findings-thickness\"\u003eKey Findings: Changes in Artery Wall Thickness\u003c\/h2\u003e\n\n\u003ch3\u003eBaseline Characteristics\u003c\/h3\u003e\n\n\u003cp\u003eAt the start of the study, \u003cstrong\u003e63% of sectors (n = 4,112)\u003c\/strong\u003e were plaque-free, meaning they had a wall thickness under 0.5 mm. The median baseline wall thickness in these plaque-free sectors was \u003cstrong\u003e0.23 mm\u003c\/strong\u003e (ranging from 0.02 to 0.49 mm). The remaining \u003cstrong\u003e2,415 sectors (37%)\u003c\/strong\u003e contained plaque, with a median wall thickness of \u003cstrong\u003e0.70 mm\u003c\/strong\u003e (ranging from 0.50 to 2.06 mm). Of these plaque sectors, \u003cstrong\u003e22% contained LRNC tissue\u003c\/strong\u003e. Plaque sectors with LRNC had a median baseline wall thickness of \u003cstrong\u003e0.76 mm\u003c\/strong\u003e, while those without LRNC had a median of \u003cstrong\u003e0.67 mm\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003ch3\u003eWhat Happened in Plaque-Free Sectors\u003c\/h3\u003e\n\n\u003cp\u003eOver the one-year study period, plaque-free sectors showed a mean increase in wall thickness (ΔWT) of \u003cstrong\u003e0.06 mm\u003c\/strong\u003e (95% confidence interval: 0.05 to 0.07 mm). This means these previously clear areas began developing new plaque—a process that \u003cstrong\u003e63% of the sectors\u003c\/strong\u003e experienced to some degree.\u003c\/p\u003e\n\n\u003cp\u003eWhen analyzing the forces involved, researchers found a striking result: \u003cstrong\u003ehigher baseline mechanical wall stress (MWS) was significantly associated with greater vessel wall growth (p \u0026lt; 0.001)\u003c\/strong\u003e. In plain terms, areas of the artery exposed to more stretching stress from blood pressure grew thicker over the year, indicating new plaque formation.\u003c\/p\u003e\n\n\u003cp\u003eA different pattern emerged for wall shear stress. Sectors exposed to lower WSS tended to show higher wall thickness increase over time, though this association fell just short of statistical significance (p = 0.058). This is consistent with previous research showing that low blood-flow friction promotes plaque initiation.\u003c\/p\u003e\n\n\u003ch3\u003eWhat Happened in Plaque Sectors\u003c\/h3\u003e\n\n\u003cp\u003eThe plaque sectors told the opposite story. These areas showed a mean decrease in wall thickness of \u003cstrong\u003e-0.07 mm\u003c\/strong\u003e (95% confidence interval: -0.08 to -0.06 mm), with \u003cstrong\u003e67% of sectors getting thinner\u003c\/strong\u003e over the year. This regression is likely explained by the statin therapy that all patients were receiving—statins are known to shrink plaques and reduce their lipid content.\u003c\/p\u003e\n\n\u003cp\u003eBoth biomechanical forces influenced how much shrinkage occurred:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher luminal MWS\u003c\/strong\u003e was associated with greater wall thickness reduction (p = 0.02). Areas with more mechanical stretching stress showed more plaque regression.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHigher WSS\u003c\/strong\u003e was also associated with greater wall thickness reduction (p \u0026lt; 0.001). Areas with more blood-flow friction regressed more.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe combination of forces mattered too. The researchers found a significant combined effect of WSS, luminal MWS, and LRNC presence on wall thickness change (p = 0.02). Specifically:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eThe \u003cstrong\u003esmallest wall thickness reduction\u003c\/strong\u003e occurred in plaque sectors exposed to both low luminal MWS and low WSS—these \"double-low\" areas were the most sluggish in responding to treatment.\u003c\/li\u003e\n  \u003cli\u003eThe \u003cstrong\u003ehighest wall thickness reduction\u003c\/strong\u003e was observed in sectors with both high luminal MWS and high WSS—these \"double-high\" areas regressed the most.\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eInterestingly, for any combination of luminal MWS and WSS, plaque sectors \u003cstrong\u003ewithout LRNC\u003c\/strong\u003e demonstrated greater wall thickness reduction than sectors with LRNC. This suggests that lipid-rich, necrotic-core-containing plaques may be more resistant to regression than fibrous plaques.\u003c\/p\u003e\n\n\u003ch2 id=\"findings-composition\"\u003eKey Findings: Changes in Plaque Composition\u003c\/h2\u003e\n\n\u003cp\u003eBeyond measuring how thick the artery walls became, the researchers tracked changes in plaque composition—specifically the amount of lipid-rich necrotic core (LRNC), which is the dangerous, inflammation-filled material inside plaques that makes them prone to rupture.\u003c\/p\u003e\n\n\u003cp\u003eOver the study year, plaque sectors showed an average \u003cstrong\u003e54% reduction in LRNC percentage\u003c\/strong\u003e (95% confidence interval: -64% to -43%). An impressive \u003cstrong\u003e85% of sectors showed a decrease in LRNC percentage\u003c\/strong\u003e—strong evidence that the statin therapy was effectively \"de-fatting\" the plaques across the board.\u003c\/p\u003e\n\n\u003cp\u003eHowever, biomechanical forces modified this response. Statistical analysis revealed that luminal MWS (p = 0.022), WSS (p = 0.004), and their interaction (p = 0.003) were all significantly associated with LRNC percentage change:\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003e\n\u003cstrong\u003eLuminal MWS showed a negative trend\u003c\/strong\u003e: Higher mechanical wall stress was associated with greater LRNC reduction.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eWSS showed a positive trend\u003c\/strong\u003e: Higher wall shear stress was associated with less LRNC reduction (or even an increase).\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp\u003eThe most clinically important finding emerged from combining the two forces: \u003cstrong\u003esectors with low MWS combined with high WSS demonstrated the highest LRNC increase (p \u0026lt; 0.01)\u003c\/strong\u003e. This \"dangerous combination\"—low stretching stress plus high blood-flow friction—was associated with a growing lipid core, even in patients receiving statin therapy. Conversely, high MWS combined with low WSS was associated with possible LRNC reduction.\u003c\/p\u003e\n\n\u003cp\u003eThis matters because LRNC is a hallmark of \u003cstrong\u003evulnerable plaque\u003c\/strong\u003e—the type most likely to rupture, cause a blood clot, and trigger a heart attack. A growing lipid core may represent transformation into a higher-risk plaque phenotype, even if overall wall thickness is decreasing.\u003c\/p\u003e\n\n\u003ch2 id=\"clinical\"\u003eWhat This Means for Patients: Clinical Implications\u003c\/h2\u003e\n\n\u003cp\u003eThis study offers several important insights that could eventually affect how heart disease is monitored and treated.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFirst, mechanical wall stress deserves more attention.\u003c\/strong\u003e For years, research on biomechanics and atherosclerosis focused almost exclusively on wall shear stress. This study demonstrates that MWS—the structural stress caused by blood pressure—is independently associated with both plaque initiation in clear arteries and plaque regression in diseased ones. The two forces were found to be essentially uncorrelated with each other (R² = 0.015 in plaque-free sectors and R² = 0.006 in plaque sectors), meaning they provide separate, complementary information about plaque risk.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSecond, the combination of forces matters more than either alone.\u003c\/strong\u003e The finding that low MWS combined with high WSS was associated with increased lipid-rich necrotic core—the most dangerous plaque component—suggests that using both biomechanical measurements together could identify \"hot spots\" at higher risk of progressing to vulnerable plaques.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThird, these findings may help explain why some plaque areas respond better to statin therapy than others.\u003c\/strong\u003e Even with all patients on statins, certain sectors showed plaque regression while others continued to develop. The biomechanical environment—specifically, how much stress and friction a given artery segment experiences—appears to influence how responsive that segment is to lipid-lowering treatment.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFourth, this could eventually lead to more personalized monitoring strategies.\u003c\/strong\u003e If computational models can identify high-risk coronary segments based on biomechanical forces, doctors might focus imaging follow-up on specific \"at-risk\" regions of the coronary tree rather than assessing the whole artery uniformly. This is still years away from routine clinical practice, but the foundation is now being laid.\u003c\/p\u003e\n\n\u003cp\u003eFor patients, the most actionable takeaway is straightforward: \u003cstrong\u003econtrolling blood pressure matters at the local level\u003c\/strong\u003e. The MWS experienced by the coronary arteries is directly driven by blood pressure. Keeping blood pressure well-controlled may reduce the damaging mechanical stress on artery walls—not just globally, but in the precise locations where plaques are forming.\u003c\/p\u003e\n\n\u003ch2 id=\"limitations\"\u003eStudy Limitations: What This Research Could Not Prove\u003c\/h2\u003e\n\n\u003cp\u003eLike all scientific studies, this research has important limitations that patients should understand.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eCalcified segments were excluded.\u003c\/strong\u003e The presence of calcium in artery cross-sections made it impossible to visualize the outer vessel wall layer (the external elastic lamina) on imaging. This meant the study was limited to \u003cstrong\u003enon-calcified cross-sections only\u003c\/strong\u003e. Since calcification is common in advanced atherosclerosis, the findings may not apply equally to heavily calcified arteries.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSide-branch segments were excluded.\u003c\/strong\u003e Cross-sections exactly at side-branch locations could not be analyzed because the finite element models required complete intactness of the artery circumference. Side branches are known to be sites of disturbed blood flow and plaque formation, so their exclusion may have removed some biologically important areas.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eLRNC borders were reconstructed, not directly measured.\u003c\/strong\u003e The outer edge of the lipid-rich necrotic core was not fully visible on either NIRS-IVUS or OCT imaging. Instead, the researchers used a previously validated algorithm to reconstruct the LRNC outer edges. While the authors argue this likely has minimal effect on luminal MWS calculations (since the reconstructed edge is far from the lumen), some inaccuracy is possible.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAll patients were on statins.\u003c\/strong\u003e This was actually a major confounder. Statins lower LDL cholesterol and reduce vascular inflammation, which hinders the \"natural\" development of atherosclerosis. The observed plaque regression in many sectors likely reflects statin effects rather than biomechanical forces alone. However, the statistical models did correct for statin treatment, and the fact that biomechanical associations persisted even after this correction strengthens the findings.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eSample size was modest.\u003c\/strong\u003e The study included 34 patients and 6,527 sectors, but the patient-level sample is relatively small. The generalizability to broader populations—including women (who made up only 8.8% of participants) and people with different risk profiles—remains uncertain.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFollow-up was only 12 months.\u003c\/strong\u003e Atherosclerosis develops over decades. A one-year window, while sufficient to detect changes in wall thickness and LRNC content, cannot capture long-term plaque behavior or clinical outcomes like heart attacks or death.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eThis is an observational association study, not a cause-and-effect experiment.\u003c\/strong\u003e While the statistical models corrected for many potential confounders, the association between biomechanical forces and plaque changes does not definitively prove that one causes the other. A randomized controlled trial would be needed to establish causality.\u003c\/p\u003e\n\n\u003ch2 id=\"recommendations\"\u003eRecommendations for Patients: What You Can Do\u003c\/h2\u003e\n\n\u003cp\u003eWhile this research is still early-stage, its findings reinforce several well-established principles that patients can apply right now to protect their heart health:\u003c\/p\u003e\n\n\u003col\u003e\n  \u003cli\u003e\n\u003cstrong\u003eTake your blood pressure medication as prescribed.\u003c\/strong\u003e This study shows that blood-pressure-related mechanical stress on artery walls is linked to plaque development. Keeping blood pressure in a healthy range directly reduces the mechanical stretch and strain on your coronary arteries.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eStay on your statin therapy.\u003c\/strong\u003e The study vividly demonstrates the power of statins: 85% of plaque sectors showed reduced lipid-rich necrotic core over one year, with an average 54% reduction in LRNC percentage. If you've been prescribed a statin, staying consistent with it is one of the most effective ways to stabilize and shrink plaque.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eControl your other risk factors.\u003c\/strong\u003e Diabetes, hypertension, smoking, and high cholesterol were all present in this patient population and were corrected for in the analysis. Managing these risk factors remains foundational for reducing both biomechanical stress and the biological processes that drive plaque formation.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eMaintain a heart-healthy lifestyle.\u003c\/strong\u003e Regular exercise, a Mediterranean-style diet, stress reduction, and weight management all contribute to better blood pressure control, healthier blood vessels, and reduced inflammation—all of which are relevant to the forces studied here.\u003c\/li\u003e\n  \u003cli\u003e\n\u003cstrong\u003eHave informed conversations with your cardiologist.\u003c\/strong\u003e If you have known coronary artery disease, ask your doctor about the state of your plaque and your treatment goals. Advanced imaging techniques like IVUS and OCT are increasingly used in research settings to characterize plaque, and understanding your personal risk factors can help guide treatment decisions.\u003c\/li\u003e\n\u003c\/ol\u003e\n\n\u003cp\u003eThis research offers hope. The fact that plaque regresses rather dramatically when patients are on statin therapy—with biomechanical forces modifying that response—suggests that heart disease is not a one-way street. With proper treatment and risk factor control, even established plaques can shrink and become less dangerous.\u003c\/p\u003e\n\n\u003c!-- ddn:faq:start --\u003e\n\u003ch2 id=\"ddn-faq\"\u003eFrequently Asked Questions\u003c\/h2\u003e\n\u003ch3\u003eWhat are the two forces on heart arteries that this research looked at?\u003c\/h3\u003e\n\u003cp\u003eThe two forces are wall shear stress, the friction from blood flowing over the artery's inner lining, and mechanical wall stress, the stretching from blood pressure. Wall shear stress is like hand drag from a car window; mechanical wall stress is like the tension in a balloon as it inflates.\u003c\/p\u003e\n\u003ch3\u003eWhat did the study find about new plaque formation in clear arteries?\u003c\/h3\u003e\n\u003cp\u003eIn previously clear artery segments, higher mechanical wall stress from blood pressure was linked to greater wall thickening over one year. This suggests that areas experiencing more stretching stress may be more likely to develop new plaque. Low wall shear stress also showed a link, though this was not statistically significant.\u003c\/p\u003e\n\u003ch3\u003eWhat did the study find about plaque shrinkage?\u003c\/h3\u003e\n\u003cp\u003ePlaque areas shrank on average by 0.07 mm over the year, likely due to statin therapy. Higher wall shear stress and higher mechanical wall stress were each linked to greater shrinkage. Plaques with both low forces shrank the least, while those with both high forces regressed the most.\u003c\/p\u003e\n\u003ch3\u003eHow did the forces affect the dangerous lipid core inside plaques?\u003c\/h3\u003e\n\u003cp\u003eOverall, the lipid-rich necrotic core shrank by 54%, and 85% of plaque areas showed improvement. But the combination of low mechanical wall stress plus high wall shear stress was linked to an increase in this dangerous lipid core, even during statin therapy, suggesting a potentially higher-risk plaque.\u003c\/p\u003e\n\u003ch3\u003eWhat are the limitations of this research?\u003c\/h3\u003e\n\u003cp\u003eThe study was small, with only 34 patients, and most were men. Calcified artery areas and side branches were excluded. Lipid core borders were reconstructed, not directly measured. All patients were on statins, and the follow-up was only 12 months. So this shows associations, not proven cause and effect.\u003c\/p\u003e\n\u003ch3\u003eWhat can patients do based on these findings?\u003c\/h3\u003e\n\u003cp\u003eTake blood pressure medications as prescribed to reduce mechanical stress on artery walls. Stay on statin therapy, which shrank plaques in most patients. Control other risk factors like diabetes, smoking, and high cholesterol. Maintain a heart-healthy lifestyle and discuss plaque imaging and treatment goals with your cardiologist.\u003c\/p\u003e\n\u003ch3\u003eWhen should a patient with coronary artery plaque consider a second opinion about using advanced imaging to assess biomechanical forces like wall shear stress and mechanical wall stress?\u003c\/h3\u003e\n\u003cp\u003eA second opinion may be helpful for a patient with coronary artery disease who wants to know whether advanced imaging (such as IVUS or OCT) could assess plaque vulnerability based on biomechanical forces like wall shear stress and mechanical wall stress. Even with statin therapy—which reduced lipid-rich necrotic core in 85% of plaque sectors—some areas exposed to low mechanical stress and high shear stress show increased lipid core. A specialist can review imaging and risk factors to clarify monitoring options. Diagnostic Detectives Network provides independent expert second opinions.\u003c\/p\u003e\n\u003c!-- ddn:faq:end --\u003e\n\n\u003ch2 id=\"source\"\u003eSource Information\u003c\/h2\u003e\n\n\u003cp\u003e\u003cstrong\u003eOriginal article title:\u003c\/strong\u003e Mechanical wall stress and wall shear stress are associated with atherosclerosis development in non-calcified coronary segments\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eAuthor:\u003c\/strong\u003e Aikaterini Tziotzioua, Eline Hartmana, Suze-Anne Kortelanda, Aad van der Lugtc, Antonius F.W. van der Steena, Joost Daemenb, Daniel Bosc,d, Jolanda Wentzela, Ali C. Akyildiza,e,*\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003ePublication:\u003c\/strong\u003e Atherosclerosis, Volume 387 (2023), Article 117387. Published by Elsevier B.V. Available online November 15, 2023.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eFunding\/affiliations:\u003c\/strong\u003e The research was conducted at the Department of Biomedical Engineering, Erasmus Medical Center, Rotterdam, the Netherlands, with contributions from the Departments of Cardiology, Radiology \u0026amp; Nuclear Medicine, and Epidemiology, as well as the Department of Biomechanical Engineering at Delft University of Technology.\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eEthics:\u003c\/strong\u003e The study was approved by the local medical ethics committee of Erasmus University Medical Center (MEC 2015-535, NL54519.078.15) and conducted in accordance with the Declaration of Helsinki and the Dutch Medical Research Involving Human Subject Act (WMO).\u003c\/p\u003e\n\n\u003cp\u003e\u003cstrong\u003eDisclosure:\u003c\/strong\u003e This is an open-access article under the CC BY license.\u003c\/p\u003e\n\n\u003cp\u003e\u003cem\u003eNote: This patient-friendly article is based on peer-reviewed research. It is intended for educational purposes and should not replace professional medical advice. Always consult your healthcare provider before making any changes to your treatment plan.\u003c\/em\u003e\u003c\/p\u003e","brand":"DiagnosticDetectives.Com","offers":[{"title":"Default Title","offer_id":47461164351644,"sku":null,"price":0.0,"currency_code":"CHF","in_stock":true}],"url":"https:\/\/diagnosticdetectives.ch\/fr\/products\/understanding-how-blood-flow-forces-affect-heart-artery-plaque-a-patients-guide-to-new-research","provider":"DiagnosticDetectives.Com","version":"1.0","type":"link"}